Benserazide

CAS 322-35-0 11 current recordsSmall Molecule

Who holds supplier records for Benserazide? 11 organisations hold a current record for Benserazide: an active US FDA Type II Drug Master File or a CEP. 11 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (4), India (2), Italy (1), Finland (1) and 2 other countries (2); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Benserazide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/benserazide

Reading the evidence

  • 11 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 6 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (11)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Benserazide. Country is the organisation's recorded country, not necessarily the manufacturing site.

China4India2Italy1Finland1Türkiye1Sweden1Country not recorded for 1
Need Benserazide sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (11)

Certificates of Suitability on the EDQM register for Benserazide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 14 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
FERMION OY EspooFI
CEP 2023-108 - Rev 02
Benserazide hydrochloride, Process 2
Nov 2026Inspected Feb 2026
Finland
SHANDONG XINHUA PHARMACEUTICAL CO., LTD. ZiboCN
CEP 2024-494 - Rev 00
Benserazide hydrochloride
Oct 2026Inspected Nov 2025
Hungary
BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED HyderabadIN
CEP 2022-150 - Rev 01
Benserazide hydrochloride
Jul 2025—
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2022-200 - Rev 01
Benserazide hydrochloride
Jul 2025Inspected May 2026
Italy
COHANCE LIFESCIENCES LIMITED HyderabadIN
CEP 2023-115 - Rev 00
Benserazide hydrochloride
Apr 2025—
CHEMI S.P.A. Cinisello BalsamoIT
CEP 2021-226 - Rev 02
Benserazide hydrochloride
Feb 2025Inspected Apr 2025
Italy
ZHEJIANG HENGKANG PHARMACEUTICAL CO., LTD. SanmenCN
CEP 2022-310 - Rev 01
Benserazide hydrochloride, Pubagang site
Dec 2023—
Deva Holding A.Ş. IstanbulTR
R0-CEP 2021-345 - Rev 00
Benserazide hydrochloride
Aug 2023—
Nexchem Pharmaceutical Co., Ltd. Jinhua CityCN
R0-CEP 2018-299 - Rev 00
Benserazide hydrochloride
Mar 2022—
MAGLE CHEMOSWED AB MalmöSE
R1-CEP 2014-202 - Rev 00
Benserazide hydrochloride
Aug 2021—
S.P. QUIMICA, S.A. RiudomsES
R1-CEP 2010-267 - Rev 02
Benserazide hydrochloride
May 2018—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Overview

Benserazide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1096979).

Chemical identity

IUPAC name
2-amino-3-hydroxy-N'-[(2,3,4-trihydroxyphenyl)methyl]propanehydrazide
Canonical SMILES
C1=CC(=C(C(=C1CNNC(=O)C(CO)N)O)O)O
InChIKey
BNQDCRGUHNALGH-UHFFFAOYSA-N
Synonyms
Benserazida, Benserazide, Benserazide (as hydrochloride), Benserazide component of madopar, Benserazide component of prolopa, Benserazide hcl, Benserazide hydrochloride, NSC-755907, RO 4-4602, RO-4-4602, Serazide, Benserazidum

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Benserazide?

11 organisations hold an active US FDA Type II Drug Master File or a CEP for Benserazide: SP QUIMICA SA, BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), CHEMI SPA (Italy), COHANCE LIFESCIENCES LTD (India), FERMION OY (Finland), SHANDONG XINHUA PHARMACEUTICAL CO LTD (China), Zhejiang Hengkang Pharmaceutical Co., Ltd. (China) and Zhejiang Huahai Pharmaceutical Co., Ltd. (China), and 3 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Benserazide Drug Master Files are active?

SP QUIMICA SA (DMF 36473). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

Does Benserazide have a European Certificate of Suitability?

Yes. 11 organisations hold a valid CEP for Benserazide on the EDQM register, including FERMION OY Espoo (FI), SHANDONG XINHUA PHARMACEUTICAL CO., LTD. Zibo (CN), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED Hyderabad (IN), ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Taizhou (CN), COHANCE LIFESCIENCES LIMITED Hyderabad (IN) and CHEMI S.P.A. Cinisello Balsamo (IT) and 5 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Benserazide supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Benserazide?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.